Intrathoracic masses in children and adolescents: a single tertiary pediatric institution experience

May Priscilla   V. Cero,; Maria Cherry   R. Añana,; Beatriz   P. Gepte,

Intrathoracic masses in children and adolescents: a single tertiary pediatric institution experience

May Priscilla V. Cero | Maria Cherry R. Añana | Beatriz P. Gepte

Abstract:

OBJECTIVES: The Cancer and Hematology Division of the PCMC receives an average of 24 cases of pediatric intrathoracic masses annually. Comprehensive data on the demographic status, clinical profile, management, and outcome are still not available. This study aims to determine the clinical features, diagnosis, management and outcome of children and adolescents with intrathoracic masses from 2017 to 2019. MATERIALS AND METHODS: Descriptive study design was utilized. Data were collected by doing a chart review. Possible associations between the clinical features and outcome were described. RESULTS: Sixty-eight (68) cases were referred from January 2017 to December 2019. Mean age at diagnosis is 8.8 years with a 2.4:1 male to female ratio. Severe wasting was seen in 21%. All subjects were symptomatic at presentation, 50% with respiratory compromise. Anterior mediastinal lesions are observed at 82% of cases. Elevated LDH was seen in 50% of the patients. Malignant hematologic lesions are the most common etiology. Steroid pretreatment was given in 40% of patients. Only a small percentage (<20%) underwent definitive treatment. Patients were symptomatic for 18 days on average before consult. It took an average of 18 days for a case to be diagnosed definitively, and 10 days from the diagnosis to start of directed treatment. Mortality rate was high at 57.4%. CONCLUSION: Patients with intrathoracic mass and malnutrition are 1.4x more likely to die. Diagnosis is the most significant factor associated with death. Observed data can be used as basis to formulate protocols which can streamline the diagnostic and therapeutic approach in these patients.

References:

Park DR, Vallieres E. The mediastinal mass. In: Mason RJ, Broaddus VC, Martin TR, King TE Jr., Schraufnagel DE, eds. Murray and Nadel’s Textbook of Respiratory Medicine. 5^th ed. Saunders; 2010
Chen CH, Wu KH, Chao YH, Weng DF, Chang JS, Lin CH. Clinical manifestation of pediatric mediastinal tumors, a single center experience. Medicine 2019; 98:32.
Kashif R. Faizan M, Anwar S. Pediatric Malignant Mediastinal Masses. Journal of the College of Physicians and Surgeons Pakistan. 2019; 258-262.
Shatani, N., Nadel, H., Potts, J., & Bray, H. Pediatric Thoracic Masses- Classic Chest Xray Findings Guide Wise Choices. ND
Alamdaran S, Estilaee S, Farrokh D, Morovatdar N. Thoracic Mass Nature Determination; What Modality Is Better in Pediatric Age? Int J Pediatr 2019; 7(8): 9921-28
Bailey SER, Ukoumunne OC, Shephard EA, Hamilton W. Clinical relevance of thrombocytosis in primary care: a prospective cohort study of cancer incidence using English electronic medical records and cancer registry data. In British Journal of General Practice. 2017
Brillantino C, Rossi E, Tambaro FP, Minelli R,Bignardi E, Cremone G, et al. Clinical and Imaging Findings Useful in the Differential Diagnosis of Most Common Childhood Mediastinal Tumors. Trans Med 2019 (9);207
Garey CL, Laituri CA, Valusek PA, et al. Management of Anterior Mediastinal Mass in Children. European Journal of Pediatric Surgery. 2011; 21:310-313
Lanzkowsky P, Lipton J, Fish J. Lanzkowsky’s Manual of Pediatric Hematology and Oncology. 6^th ed. Elsevier; 2016
Nasir S, Jabbar R, Rehman F, Khalid M, Khan M R, Haque A. Morbidity and Mortality Associated with Pediatric Critical Mediastinal Mass Syndrome. Cureus 2020; 12(6) e8838
Pizzo P, Poplack D. Principles and Practice of Pediatric Oncology. 7^th ed. Wolters Kluwer; 2016
Orman G, Masand P, Hicks J, Huisman TAGM, Guillerman RP. Pediatric thoracic mass lesions; Beyond the common. European Journal of Radiology Open. 2020 (7); 100240
Naeser E, Moller H, Fredberg U, Frystyk J, Vedsted P. Routine blood tests and probability of cancer in patients referred with non-specific serious symptoms: a cohort study. In BMC Cancer. 2017
Nicholson B, Aveyard P, Koshiaris C, Perera R, Hamilton W, Oke J, Hobbs FDR. Combining simple blood tests to identify primary patients with unexpected weight loss for cancer investigation: Clinical risk score development, internal validation, and net benefit analysis. In PLOS Medicine. 2021
Dishop MK, Kuruvilla S. Primary and Metastatic Lung Tumors in the Pediatric Population: A Review and 25-Year Experience at a Large Children's Hospital. Arch Pathol Lab Med. 2008; 1079-1103.
Takeda S, Miyoshi S, Minami M, Matsuda H. Intrathoracic neurogenic tumors- 50 years’ experience in a Japanese institution. European Journal of Cardio-thoracic Surgery 26. 2004; 810-812
Daniel WW. Biostatistics: A Foundation for Analysis in the Health Sciences. 7th edition. New York: John Wiley & Sons. (1999)
Green K, Behjati S, Cheng D. Fifteen-minute consultation: Obvious and not-so-obvious mediastinal masses. Arc Dis Child Educ Pract Ed. 2019 (104):298-303
McCarville, M. Malignant pulmonary and mediastinal tumors in children: differential diagnoses. Cancer Imaging 10. 2010; S35-S41
Naeem F, Metzger M, Arnold S, Adderson E. Distinguishing Benign Mediastinal Masses from Malignancy in a Histoplasmosis-Endemic Region. J Pediatr. 2015; 167;409-15
Ross J, Spector L. Cancers in Children. In Cancer Epidemiology and Prevention. Oxford University Press. 2009
Wright CD. Mediastinal Tumors and Cysts in the Pediatric Population. Thorac Surg Clin 19. 2009; 47-61